Shared links between type 2 diabetes mellitus and Alzheimer's disease: A review

Diabetes & Metabolic Syndrome
Khyati Mittal, Deepshikha Pande Katare

Abstract

Epidemiological studies have proved that, there are pathophysiological connections between Type 2 Diabetes Mellitus (T2DM) and Alzheimer's disease (AD). Diabetic patients have higher incidences of cognitive impairment and hence they are more at the risk of developing AD. Some of the recent evidences have majorly stated the effects of insulin resistance in the disturbance of various biological processes and signaling pathways. Both hyperglycemia and hypoglycemic conditions contributes in dysfunctioning of cognitive abilities and functions. The present review summarizes the evidences which establish the possible links between the two pathologies on the account of molecular, biochemical and at histopathological level. The information regarding their interactions was collected from different databases and journals. The gathered information will clearly establish the link among the two pathologies and will be helpful in future for the development of drugs for Type 3 Diabetes.

References

Aug 1, 1997·The Journal of Biological Chemistry·M Hong, V M Lee
Dec 22, 2000·Neurobiology of Aging·P L HarrisM A Smith
Apr 8, 2003·Current Pharmaceutical Design·Stephen C WoodsMichael W Schwartz
Jul 16, 2003·Archives of Internal Medicine·Deborah GustafsonIngmar Skoog
Jan 6, 2004·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·G S Hotamisligil
Feb 26, 2004·Lancet Neurology·Suzanne Craft, G Stennis Watson
Jun 11, 2004·Journal of Neurochemistry·Ratan V BhatJesús Avila
Aug 4, 2004·Medical Hypotheses·M Takeuchi, S Yamagishi
Apr 13, 2005·Archives of Internal Medicine·Bret H GoodpasterAnne B Newman
Oct 7, 2005·The Journal of Biological Chemistry·Veronica Hirsch-ReinshagenCheryl L Wellington
Nov 25, 2005·Diabetes·Susanna FreudeMarkus Schubert
Dec 6, 2006·Drug Metabolism Reviews·Lawrence M SayreXiaoxia Tang
Jan 11, 2007·Archives of Neurology·George RazayGordon Wilcock
Apr 25, 2007·Journal of Neuroscience Research·Akanksha ThakurXiongwei Zhu
Jul 25, 2007·Journal of Internal Medicine·O WiklundL M Hultén
Sep 28, 2007·Current Pharmaceutical Design·Sho-ichi YamagishiSeiya Okuda
Nov 30, 2007·Current Molecular Medicine·Hideaki KanetoMunehide Matsuhisa
Jun 28, 2014·Journal of Neuroimmunology·Lindsay J SpielmanAndis Klegeris

❮ Previous
Next ❯

Citations

Aug 23, 2016·BioMed Research International·J Mendiola-PrecomaG Garcia-Alcocer
Aug 26, 2016·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Xiao-Xia HuJian-Ping Cai
May 7, 2016·Journal of Cellular Biochemistry·Marta Olivera-Santa CatalinaFrancisco Centeno
Sep 7, 2016·Behavioural Brain Research·Nan-Qu HuangFeng Jin
Jun 21, 2016·Annals of Medicine·Olga PivovarovaNatalia Rudovich
Mar 30, 2017·Acta Diabetologica·Ana I Arroba, Ángela M Valverde
Aug 15, 2019·CNS Neuroscience & Therapeutics·Li WangXiao-Hui Wang
May 30, 2020·International Journal of Molecular Sciences·Krish ChandrasekaranJames William Russell
Aug 9, 2016·Reviews in the Neurosciences·Siew Ying Wong, Bor Luen Tang
Dec 8, 2017·Dementia & Neuropsychologia·Aparecida Marcelino de Nazareth
Nov 16, 2018·Frontiers in Neurology·Young-Kook KimJuhyun Song
Feb 23, 2020·Journal of Diabetes Research·Yanan SunXu He
Jun 21, 2019·Journal of Nutritional Science·Kristi M Crowe-WhiteAmy C Ellis
Apr 17, 2019·International Journal of Molecular Sciences·Anita GołaszewskaArkadiusz Orzechowski
Sep 29, 2019·International Journal of Environmental Research and Public Health·Wei-Ti SuChing-Hua Hsieh
Feb 23, 2020·International Journal of Molecular Sciences·Amit Koren-ItonDaniel M Michaelson
Dec 20, 2018·International Journal of Molecular Sciences·Cini Mathew JohnFazlin Mohd Fauzi
Sep 21, 2017·Journal of Biomedical Science·Waqar AhmadSidra Rehman
Dec 16, 2020·Molecular and Cellular Endocrinology·Lucas ZangerolamoHelena C L Barbosa
Feb 14, 2021·Biomolecules·Maria Jose Carranza-NavalAngel Del Marco
Feb 27, 2021·Life Sciences·Lucas ZangerolamoHelena C L Barbosa
Apr 4, 2021·Biomolecules·Masayoshi TakeuchiTamihide Matsunaga

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Alzheimer's Disease: APOE

Apolipoprotein E (APOE) polymorphic alleles are major genetic risk factors for Alzheimer's disease. Discover the latest research on APOE and other genetic determinants of Alzheimer's disease here.

Blood Brain Barrier & Cytokines

Some cytokines are able to cross the blood brain barrier through transport systems and enter the cerebrospinal fluid and interstitial fluid spaces. Here is the latest research on cytokines crossing the blood brain barrier and how this can affect tissues within the CNS.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Blood-Brain Barrier Transport in Neurodegeneration

The blood brain barrier is important for regulating the movement of biomolecules in and out of the brain. For example, membrane transporters in the blood brain barrier can be essential for regulating drug movement and dysregulation of these processes may play a role in neurodegeneration. This feed follows the latest research on this topic.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Related Papers

World Journal of Diabetes
Mario Barbagallo, Ligia J Dominguez
British Journal of Clinical Pharmacology
Kawser AkterRobert B Raffa
Pediatrics International : Official Journal of the Japan Pediatric Society
Tatsuhiko UrakamiHideo Mugishima
© 2022 Meta ULC. All rights reserved